Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Allergan PLC (NYSE:AGN)

Paying users zone. Data is hidden behind: .


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Statement of Comprehensive Income

Beginner level

Allergan PLC, consolidated statement of comprehensive income

US$ in thousands

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net income (loss)
Foreign currency translation gains (losses)
Net impact of other-than-temporary loss on investment in Teva securities
Impact of Teva Transaction
Unrealized gains (losses), net of tax
Other comprehensive income (loss), net of tax
Comprehensive income (loss)
Comprehensive income attributable to noncontrolling interest
Comprehensive income (loss) attributable to ordinary shareholders

Based on: 10-K (filing date: 2020-02-18), 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26).

Comprehensive income item Description The company
Net income (loss) attributable to shareholders The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Allergan PLC’s net income (loss) attributable to shareholders decreased from 2017 to 2018 and from 2018 to 2019.
Comprehensive income (loss) attributable to ordinary shareholders Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Allergan PLC’s comprehensive income (loss) attributable to ordinary shareholders decreased from 2017 to 2018 but then slightly increased from 2018 to 2019.